-transparent.png){kind=logo}
Treatment of the myeloid blast phase of chronic granulocytic leukemia is still a major problem in clinical hematology. Alternate-day plicamycin and hydroxyurea treatment was reported to induce remissions in the majority of patients with myeloid blast phase by Koller and Miller in 1986 Subsequently we treated eight patients according to this regimen. Complete remissions could not be achieved and no prolongation of median survival was observed. In two patients treatment had to be discontinued due to severe toxicity.
Related Publications
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
December 1986,
The New England journal of medicine,
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
January 1990,
Haematologica,
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
June 1988,
Onkologie,
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
January 1991,
Haematologica,
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
January 1989,
Medicina (Florence, Italy),
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
July 1982,
The Journal of the Association of Physicians of India,
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
April 1990,
Hematology/oncology clinics of North America,
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
January 1989,
Cancer chemotherapy and pharmacology,
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
January 2022,
Clinical Medicine Insights. Oncology,
L H Trümper, and
A D Ho, and
W Hunstein, and
H van der Lelie, and
R Goudsmit
December 2016,
Blood advances,
